E-cadherin mutations and cell motility: A genotype-phenotype correlation

Experimental Cell Research

Volumn 315, Issue 8, 2009, Pages 1393-1402

  Mateus, Ana Rita ^a,b   Simões Correia, Joana ^a   Figueiredo, Joana ^a   Heindl, Stefan ^b   Alves, Catarina Castro ^a,b   Suriano, Gianpaolo ^a,c   Luber, Birgit ^b   Seruca, Raquel ^a,c  

^a UNIVERSITY OF PORTO   (Portugal)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c University of Porto   (Portugal)

Author keywords

CDH1; Cell motility; Cell signalling; Diffuse carcinoma; E cadherin; EGFR; Familial cancer; Gastric cancer; Germline mutations; HDGC

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN TYROSINE KINASE; UVOMORULIN;

ANIMAL CELL; ARTICLE; CELL MOTILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENOTYPE PHENOTYPE CORRELATION; MISSENSE MUTATION; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STOMACH CANCER;

EID: 64049089800     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.02.020     Document Type: Article

References (48)

1. Shore E.M., and Nelson W.J. Biosynthesis of the cell adhesion molecule uvomorulin (E-cadherin) in Madin-Darby canine kidney epithelial cells. J. Biol. Chem. 266 (1991) 19672-19680
2. Pertz O., Bozic D., Koch A.W., Fauser C., Brancaccio A., and Engel J. A new crystal structure, Ca2+ dependence and mutational analysis reveal molecular details of E-cadherin homoassociation. EMBO J. 18 (1999) 1738-1747
3. Leckband D., and Sivasankar S. Mechanism of homophilic cadherin adhesion. Curr. Opin. Cell Biol. 12 (2000) 587-592
4. Chen H., Paradies N.E., Fedor-Chaiken M., and Brackenbury R. E-cadherin mediates adhesion and suppresses cell motility via distinct mechanisms. J. Cell. Sci. 110 Pt 3 (1997) 345-356
5. Jamora C., and Fuchs E. Intercellular adhesion, signalling and the cytoskeleton. Nat. Cell Biol. 4 (2002) E101-E108
6. Mareel M., and Leroy A. Clinical, cellular, and molecular aspects of cancer invasion. Physiol. Rev. 83 (2003) 337-376
7. Yap A.S., and Kovacs E.M. Direct cadherin-activated cell signaling: a view from the plasma membrane. J. Cell Biol. 160 (2003) 11-16
8. Crepaldi T., Pollack A.L., Prat M., Zborek A., Mostov K., and Comoglio P.M. Targeting of the SF/HGF receptor to the basolateral domain of polarized epithelial cells. J. Cell Biol. 125 (1994) 313-320
9. Hoschuetzky H., Aberle H., and Kemler R. Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor. J. Cell Biol. 127 (1994) 1375-1380
10. Christofori G. Changing neighbours, changing behaviour: cell adhesion molecule-mediated signalling during tumour progression. EMBO J. 22 (2003) 2318-2323
11. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am. J. Pathol. 153 (1998) 333-339
12. Pereira P.S., Teixeira A., Pinho S., Ferreira P., Fernandes J., Oliveira C., Seruca R., Suriano G., and Casares F. E-cadherin missense mutations, associated with hereditary diffuse gastric cancer (HDGC) syndrome, display distinct invasive behaviors and genetic nteractions with the Wnt and Notch pathways in Drosophila epithelia. Hum. Mol. Genet. 15 (2006) 1704-1712
13. Suriano G., Mulholland D., de Wever O., Ferreira P., Mateus A.R., Bruyneel E., Nelson C.C., Mareel M.M., Yokota J., Huntsman D., and Seruca R. The intracellular E-cadherin germline mutation V832 M lacks the ability to mediate cell-cell adhesion and to suppress invasion. Oncogene 22 (2003) 5716-5719
14. Suriano G., Oliveira C., Ferreira P., Machado J.C., Bordin M.C., De Wever O., Bruyneel E.A., Moguilevsky N., Grehan N., Porter T.R., Richards F.M., Hruban R.H., Roviello F., Huntsman D., Mareel M., Carneiro F., Caldas C., and Seruca R. Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands. Hum. Mol. Genet. 12 (2003) 575-582
15. G. Suriano, M.J. Oliviera, D. Huntsman, A.R. Mateus, P. Ferreira, F. Casares, C. Oliviera, F. Carneiro, JC. Machado, M. Mareel, R. Seruca. E-cadherin germline missense mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of cells. Hum. Mol. Genet. 12 (2003) 3007--3016.
16. Mateus A.R., Seruca R., Machado J.C., Keller G., Oliveira M.J., Suriano G., and Luber B. EGFR regulates RhoA-GTP dependent cell motility in E-cadherin mutant cells. Hum. Mol. Genet. 16 (2007) 1639-1647
17. Fujita Y., Krause G., Scheffner M., Zechner D., Leddy H.E., Behrens J., Sommer T., and Birchmeier W. Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat. Cell Biol. 4 (2002) 222-231
18. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2 (2002) 442-454
19. Pece S., and Gutkind J.S. Signaling from E-cadherins to the MAPK pathway by the recruitment and activation of epidermal growth factor receptors upon cell-cell contact formation. J. Biol. Chem. 275 (2000) 41227-41233
20. Qian X., Karpova T., Sheppard A.M., McNally J., and Lowy D.R. E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases. EMBO J. 23 (2004) 1739-1748
21. Yarden Y., and Sliwkowski M.X. Untangling the ErbB signalling network. Nat. Rev. Mol. Cell. Biol. 2 (2001) 127-137
22. Gottardi C.J., and Gumbiner B.M. Adhesion signaling: how beta-catenin interacts with its partners. Curr. Biol. 11 (2001) R792-R794
23. Biscardi J.S., Tice D.A., and Parsons S.J. c-Src, receptor tyrosine kinases, and human cancer. Adv. Cancer Res. 76 (1999) 61-119
24. Hauck C.R., Hsia D.A., and Schlaepfer D.D. Focal adhesion kinase facilitates platelet-derived growth factor-BB-stimulated ERK2 activation required for chemotaxis migration of vascular smooth muscle cells. J. Biol. Chem. 275 (2000) 41092-41099
25. Corso G., Roviello F., Paredes J., Pedrazzani C., Novais M., Correia J., Marrelli D., Cirnes L., Seruca R., Oliveira C., and Suriano G. Characterization of the P373L E-cadherin germline missense mutation and implication for clinical management. Eur. J. Surg. Oncol. 33 (2007) 1061-1067
26. Simoes-Correia J., Figueiredo J., Oliveira C., van Hengel J., Seruca R., van Roy F., and Suriano G. Endoplasmic Reticulum Quality Control: a new mechanism of E-cadherin regulation and its implication in cancer. Hum. Mol. Genet. 17 (2008) 3566-3576
27. Fuchs M., Hutzler P., Brunner I., Schlegel J., Mages J., Reuning U., Hapke S., Duyster J., Hirohashi S., Genda T., Sakamoto M., Uberall F., Hofler H., Becker K.F., and Luber B. Motility enhancement by tumor-derived mutant E-cadherin is sensitive to treatment with epidermal growth factor receptor and phosphatidylinositol 3-kinase inhibitors. Exp. Cell Res. 276 (2002) 129-141
28. Cunningham B.A., Leutzinger Y., Gallin W.J., Sorkin B.C., and Edelman G.M. Linear organization of the liver cell adhesion molecule L-CAM. Proc. Natl. Acad. Sci. U. S. A. 81 (1984) 5787-5791
29. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
30. Fincham V.J., James M., Frame M.C., and Winder S.J. Active ERK/MAP kinase is targeted to newly forming cell-matrix adhesions by integrin engagement and v-Src. EMBO J. 19 (2000) 2911-2923
31. Gabbert H.E., Mueller W., Schneiders A., Meier S., Moll R., Birchmeier W., and Hommel G. Prognostic value of E-cadherin expression in 413 gastric carcinomas. Int. J. Cancer 69 (1996) 184-189
32. Popov Z., Gil-Diez de Medina S., Lefrere-Belda M.A., Hoznek A., Bastuji-Garin S., Abbou C.C., Thiery J.P., Radvanyi F., and Chopin D.K. Low E-cadherin expression in bladder cancer at the transcriptional and protein level provides prognostic information. Br. J. Cancer 83 (2000) 209-214
33. Bremm A., Walch A., Fuchs M., Mages J., Duyster J., Keller G., Hermannstadter C., Becker K.F., Rauser S., Langer R., von Weyhern C.H., Hofler H., and Luber B. Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations. Cancer Res. 68 (2008) 707-714
34. den Hartigh J.C., van Bergen en Henegouwen P.M., Verkleij A.J., and Boonstra J. The EGF receptor is an actin-binding protein. J. Cell Biol. 119 (1992) 349-355
35. Mao W., Irby R., Coppola D., Fu L., Wloch M., Turner J., Yu H., Garcia R., Jove R., and Yeatman T.J. Activation of c-Src by receptor tyrosine kinases in human colon cancer cells with high metastatic potential. Oncogene 15 (1997) 3083-3090
36. Glading A., Chang P., Lauffenburger D.A., and Wells A. Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway. J. Biol. Chem. 275 (2000) 2390-2398
37. Hamaguchi M., Matsuyoshi N., Ohnishi Y., Gotoh B., Takeichi M., and Nagai Y. p60v-src causes tyrosine phosphorylation and inactivation of the N-cadherin-catenin cell adhesion system. EMBO J. 12 (1993) 307-314
38. Matsuyoshi N., Hamaguchi M., Taniguchi S., Nagafuchi A., Tsukita S., and Takeichi M. Cadherin-mediated cell-cell adhesion is perturbed by v-src tyrosine phosphorylation in metastatic fibroblasts. J. Cell Biol. 118 (1992) 703-714
39. Tsukita S., Oishi K., Akiyama T., Yamanashi Y., Yamamoto T., and Tsukita S. Specific proto-oncogenic tyrosine kinases of src family are enriched in cell-to-cell adherens junctions where the level of tyrosine phosphorylation is elevated. J. Cell Biol. 113 (1991) 867-879
40. Volberg T., Zick Y., Dror R., Sabanay I., Gilon C., Levitzki A., and Geiger B. The effect of tyrosine-specific protein phosphorylation on the assembly of adherens-type junctions. EMBO J. 11 (1992) 1733-1742
41. Moon W.S., Tarnawski A.S., Chai J., Yang J.T., and Majumdar A.P. Reduced expression of epidermal growth factor receptor related protein in gastric cancer. Gut 54 (2005) 201-206
42. More H., Humar B., Weber W., Ward R., Christian A., Lintott C., Graziano F., Ruzzo A.M., Acosta E., Boman B., Harlan M., Ferreira P., Seruca R., Suriano G., and Guilford P. Identification of seven novel germline mutations in the human E-cadherin (CDH1) gene. Hum. Mutat. 28 (2007) 203
43. Brooks-Wilson A.R., Kaurah P., Suriano G., Leach S., Senz J., Grehan N., Butterfield Y.S., Jeyes J., Schinas J., Bacani J., Kelsey M., Ferreira P., MacGillivray B., MacLeod P., Micek M., Ford J., Foulkes W., Australie K., Greenberg C., LaPointe M., Gilpin C., Nikkel S., Gilchrist D., Hughes R., Jackson C.E., Monaghan K.G., Oliveira M.J., Seruca R., Gallinger S., Caldas C., and Huntsman D. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J. Med. Genet. 41 (2004) 508-517
44. Kim H.C., Wheeler J.M., Kim J.C., Ilyas M., Beck N.E., Kim B.S., Park K.C., and Bodmer W.F. The E-cadherin gene (CDH1) variants T340A and L599V in gastric and colorectal cancer patients in Korea. Gut. 47 (2000) 262-267
45. Oliveira C., Bordin M.C., Grehan N., Huntsman D., Suriano G., Machado J.C., Kiviluoto T., Aaltonen L., Jackson C.E., Seruca R., and Caldas C. Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred. Hum. Mutat. 19 (2002) 510-517
46. Roviello F., Corso G., Pedrazzani C., Marrelli D., De Falco G., Berardi A., Garosi L., Suriano G., Vindigni C., De Stefano A., Leoncini L., Seruca R., and Pinto E. Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an Italian family. Eur. J. Surg. Oncol. 33 (2007) 448-451
47. Kaurah P., MacMillan A., Boyd N., Senz J., De Luca A., Chun N., Suriano G., Zaor S., Van Manen L., Gilpin C., Nikkel S., Connolly-Wilson M., Weissman S., Rubinstein W.S., Sebold C., Greenstein R., Stroop J., Yim D., Panzini B., McKinnon W., Greenblatt M., Wirtzfeld D., Fontaine D., Coit D., Yoon S., Chung D., Lauwers G., Pizzuti A., Vaccaro C., Redal M.A., Oliveira C., Tischkowitz M., Olschwang S., Gallinger S., Lynch H., Green J., Ford J., Pharoah P., Fernandez B., and Huntsman D. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. Jama. 297 (2007) 2360-2372
48. Keller G., Vogelsang H., Becker I., Plaschke S., Ott K., Suriano G., Mateus A.R., Seruca R., Biedermann K., Huntsman D., Doring C., Holinski-Feder E., Neutzling A., Siewert J.R., and Hofler H. Germline mutations of the E-cadherin (CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients. J. Med. Genet. 41 (2004) e89